Followers | 3176 |
Posts | 152672 |
Boards Moderated | 4 |
Alias Born | 06/03/2011 |
Tuesday, June 13, 2023 9:43:19 AM
Recent YS News
- YS Biopharma Announces Name Change to LakeShore Biopharma • PR Newswire (US) • 05/24/2024 11:30:00 AM
- YS Biopharma Announces Results of Extraordinary General Meeting • PR Newswire (US) • 05/21/2024 08:15:00 PM
- YS Biopharma to Hold Extraordinary General Meeting on May 21, 2024 and Announces the Appointment of Interim Chief Executive Officer • PR Newswire (US) • 05/07/2024 08:20:00 PM
- YS Biopharma Receives Additional 180 Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule • PR Newswire (US) • 04/29/2024 12:00:00 PM
- YS Biopharma Announces Unaudited Financial Results for the First Nine Months of Fiscal Year 2024 • PR Newswire (US) • 04/19/2024 11:00:00 AM
- YS Biopharma Granted Phase I Clinical Trial License of Therapeutic Chronic Hepatitis B Virus Vaccine • PR Newswire (US) • 04/18/2024 12:00:00 PM
- YS Biopharma to Report First Nine Months of Fiscal Year 2024 Financial Results on April 19, 2024 • PR Newswire (US) • 04/16/2024 12:00:00 PM
- YS Biopharma Announces Positive Interim Results of Pivotal Phase 3 Clinical Study of PIKA Rabies Vaccine • PR Newswire (US) • 04/09/2024 12:00:00 PM
- YS Biopharma Announces Full Repayment of US$40,000,000 Loan Facility • PR Newswire (US) • 04/03/2024 12:00:00 PM
- YS Biopharma Announces Board Changes and Strategic Leadership Appointments in Chinese Subsidiaries • PR Newswire (US) • 03/05/2024 01:00:00 PM
- YS Biopharma Announces Results of Extraordinary General Meeting held on February 22, 2024 • PR Newswire (US) • 02/22/2024 10:00:00 PM
- /C O R R E C T I O N -- YS Biopharma Co., Ltd./ • PR Newswire (US) • 02/18/2024 09:30:00 AM
- YS Biopharma Announces Results of Extraordinary General Meeting and Responds to False Statements about the Meeting • PR Newswire (US) • 02/17/2024 01:20:00 AM
- YS Biopharma to Hold an Extraordinary General Meeting on February 22, 2024 pursuant to a Shareholder Requisition to Enhance Corporate Governance • PR Newswire (US) • 02/14/2024 01:00:00 PM
- YS Biopharma Announces Appointment of New Directors • PR Newswire (US) • 02/14/2024 12:50:00 PM
- YS Biopharma Responds to a Notice of Extraordinary General Meeting of Shareholders of YS Biopharma Co., Ltd. • PR Newswire (US) • 02/12/2024 01:50:00 PM
- YS Biopharma Announces US$40 Million Private Placement Financing • PR Newswire (US) • 02/09/2024 11:30:00 AM
- Shareholders of YS Biopharma Announce an Extraordinary General Meeting • PR Newswire (US) • 02/08/2024 11:10:00 PM
- YS Biopharma Announces Unaudited Financial Results for the First Half of Fiscal Year 2024 • PR Newswire (US) • 01/22/2024 10:00:00 PM
- YS Biopharma Announces Changes to its Board Committees • PR Newswire (US) • 01/08/2024 01:00:00 PM
- YS Biopharma Responds to Unauthorized Press Release Regarding Extraordinary General Meeting • PR Newswire (US) • 12/20/2023 09:30:00 PM
- YS Biopharma Co., Ltd. to Hold Extraordinary General Meeting on December 28, 2023 • PR Newswire (US) • 12/20/2023 01:56:00 PM
- Noble Capital Markets Initiates Coverage on YS Biopharma With Outperform Rating and US$5.25 Price Target • PR Newswire (US) • 11/14/2023 01:30:00 PM
- YS Biopharma Announces Completion of Subject Enrollment in Pivotal Phase 3 Clinical Trial of PIKA Rabies Vaccine • PR Newswire (US) • 10/31/2023 12:30:00 PM
- YS Biopharma Announces Receipt of Nasdaq Notice • PR Newswire (US) • 10/26/2023 12:30:00 PM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM